BR0213360A - Processo para a preparação do 14beta-hidróxi-bacatina iii-1,14 -carbonato - Google Patents

Processo para a preparação do 14beta-hidróxi-bacatina iii-1,14 -carbonato

Info

Publication number
BR0213360A
BR0213360A BR0213360-1A BR0213360A BR0213360A BR 0213360 A BR0213360 A BR 0213360A BR 0213360 A BR0213360 A BR 0213360A BR 0213360 A BR0213360 A BR 0213360A
Authority
BR
Brazil
Prior art keywords
preparation
carbonate
baccatin iii
iii
bacatine
Prior art date
Application number
BR0213360-1A
Other languages
English (en)
Other versions
BR0213360B1 (pt
Inventor
Ezio Bombardelli
Gabriele Fontana
Maria Luisa Gelmi
Donato Pocar
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of BR0213360A publication Critical patent/BR0213360A/pt
Publication of BR0213360B1 publication Critical patent/BR0213360B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DO 14BETAHIDRóXI-BACATINA III-1,14-CARBONATO". Um processo para a preparação de 14<225>-hidróxi-bacatina III-1,14-carbonato útil para a preparação de novos derivados de taxano com atividade antitumor.
BRPI0213360-1B1A 2001-10-19 2002-07-18 Processo para a preparação do 14beta-hidróxi-bacatina iii-1,14 -carbonato e seus compostos intermediários BR0213360B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2001MI002186A ITMI20012186A1 (it) 2001-10-19 2001-10-19 Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
ITMI2001A002186 2001-10-19
PCT/EP2002/008005 WO2003035633A1 (en) 2001-10-19 2002-07-18 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate

Publications (2)

Publication Number Publication Date
BR0213360A true BR0213360A (pt) 2004-10-26
BR0213360B1 BR0213360B1 (pt) 2014-04-15

Family

ID=11448529

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0213360-1B1A BR0213360B1 (pt) 2001-10-19 2002-07-18 Processo para a preparação do 14beta-hidróxi-bacatina iii-1,14 -carbonato e seus compostos intermediários

Country Status (20)

Country Link
US (1) US7078432B2 (pt)
EP (1) EP1436277B1 (pt)
JP (1) JP4454310B2 (pt)
KR (1) KR100896542B1 (pt)
CN (1) CN1271061C (pt)
AT (1) ATE537160T1 (pt)
AU (1) AU2002328918B2 (pt)
BR (1) BR0213360B1 (pt)
CA (1) CA2463915C (pt)
DK (1) DK1436277T3 (pt)
ES (1) ES2376162T3 (pt)
HK (1) HK1069170A1 (pt)
HU (1) HUP0401989A3 (pt)
IL (1) IL161443A0 (pt)
IT (1) ITMI20012186A1 (pt)
MX (1) MXPA04003519A (pt)
NO (1) NO328562B1 (pt)
PL (1) PL368122A1 (pt)
RU (1) RU2291866C2 (pt)
WO (1) WO2003035633A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
ES2389518T3 (es) 2008-01-18 2012-10-26 Indena S.P.A. Formas sólidas de ortataxel
CN103450118A (zh) * 2013-09-18 2013-12-18 江苏红豆杉药业有限公司 一种半合成法制备紫杉醇的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254517B (it) 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
FR2732341A1 (fr) 1995-03-27 1996-10-04 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
IT1275435B (it) 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono
IT1283633B1 (it) 1996-05-10 1998-04-23 Indena Spa Derivati tassanici loro sintesi e formulazioni che li contengono
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
IT1318678B1 (it) 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato

Also Published As

Publication number Publication date
BR0213360B1 (pt) 2014-04-15
US20040266859A1 (en) 2004-12-30
HUP0401989A2 (hu) 2005-01-28
ATE537160T1 (de) 2011-12-15
ITMI20012186A1 (it) 2003-04-19
RU2004111669A (ru) 2005-04-20
ES2376162T3 (es) 2012-03-09
JP2005512977A (ja) 2005-05-12
EP1436277B1 (en) 2011-12-14
RU2291866C2 (ru) 2007-01-20
HUP0401989A3 (en) 2007-05-29
NO328562B1 (no) 2010-03-22
MXPA04003519A (es) 2004-07-23
DK1436277T3 (da) 2012-01-23
CA2463915A1 (en) 2003-05-01
CN1271061C (zh) 2006-08-23
WO2003035633A1 (en) 2003-05-01
KR20040045023A (ko) 2004-05-31
JP4454310B2 (ja) 2010-04-21
PL368122A1 (en) 2005-03-21
IL161443A0 (en) 2004-09-27
NO20041537L (no) 2004-04-15
EP1436277A1 (en) 2004-07-14
KR100896542B1 (ko) 2009-05-07
US7078432B2 (en) 2006-07-18
HK1069170A1 (en) 2005-05-13
AU2002328918B2 (en) 2008-09-04
CA2463915C (en) 2009-11-24
CN1571779A (zh) 2005-01-26

Similar Documents

Publication Publication Date Title
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
BR0209580A (pt) Derivados de ciclohexan-1, 4 diamina substituìdos
UY26495A1 (es) &#34; derivados de tiazolilamida&#34;
UY27381A1 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
BR9909739A (pt) Benzotiadiazóis e derivados
HK1088325A1 (en) Process for the preparation of baccatin III derivatives
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
IL185921A0 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate
BR0213360A (pt) Processo para a preparação do 14beta-hidróxi-bacatina iii-1,14 -carbonato
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
MXPA03008248A (es) Agentes colorantes para fibras de queratina que contienen derivados de n-heteroarilmetil-m-fenilendiamina, asi como nuevos derivados de n-heteroarilmetil-m-fenilendiamina.
BR0311761A (pt) Processo para a preparação de 4,6-dicloro-5-fluorpirimidina
BR0315348A (pt) Processo para a preparação de um composto, e composto
BR0009795A (pt) Processo para a ppeparação de um composto da fórmula (i), e, composto
BR0306702A (pt) Processo para a preparação de um composto, composto, processo para a preparação de fitona, e, vitamina e obtida de fitona
BR0203893A (pt) Processo para a preparação de um componente catalisador sólido
ECSP992932A (es) Derivados de epotilona 12,13- modificados

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI. C07D 305/14, A61K 31/335, A61P 31/00, A61P 35/00

Ipc: C07D 305/14 (2011.01), A61K 31/335 (2011.01), A61P

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/04/2014, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2679 DE 10-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.